News Releases Year None20242023202220212020201920182017 NuCana Announces Receipt of Nasdaq Notice May 12, 2023 NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action Apr 14, 2023 NuCana Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update Apr 04, 2023 Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana’s ‘190 Patent is Not Valid Mar 24, 2023 NuCana to Participate in Two Upcoming Investor Conferences Feb 28, 2023 NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement Jan 23, 2023 NuCana Announces Receipt of NASDAQ Notice Jan 06, 2023 NuCana to Host Investor Meetings During the J.P. Morgan Healthcare Conference Jan 03, 2023 NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update Nov 16, 2022 NuCana to Present at the Jefferies London Healthcare Conference Nov 08, 2022 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action Apr 14, 2023
NuCana Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update Apr 04, 2023
Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana’s ‘190 Patent is Not Valid Mar 24, 2023